39 related articles for article (PubMed ID: 10705007)
1. An Overview of Head and Neck Tumor Reirradiation: What Has Been Achieved So Far?
Gordon K; Smyk D; Gulidov I; Golubev K; Fatkhudinov T
Cancers (Basel); 2023 Sep; 15(17):. PubMed ID: 37686685
[TBL] [Abstract][Full Text] [Related]
2. The CBP/β-Catenin Antagonist, ICG-001, Inhibits Tumor Metastasis via Blocking of the miR-134/ITGB1 Axis-Mediated Cell Adhesion in Nasopharyngeal Carcinoma.
Chen L; Chiang YC; Chan LS; Chau WY; Lung ML; Kahn M; Lo KW; Mak NK; Lung HL
Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804897
[TBL] [Abstract][Full Text] [Related]
3. Re-irradiation with Moderate Hypo-fractionation Using Intensity Modulated Photon or Proton Radiation Therapy in Locally Recurrent Squamous Cell Carcinoma of Nasopharynx.
Nam H; Ahn YC; Yang K; Oh D; Noh JM
Cancer Res Treat; 2022 Jan; 54(1):96-108. PubMed ID: 33781049
[TBL] [Abstract][Full Text] [Related]
4. Volumetric parameters derived from FLT-PET performed at completion of treatment predict efficacy of Carbon-ion Radiotherapy in patients with locally recurrent Nasopharyngeal Carcinoma.
Hu J; Yang Z; Gao J; Hu W; Yang J; Qiu X; Zhang Y; Ma G; Kong L; Lu JJ
J Cancer; 2020; 11(23):7073-7080. PubMed ID: 33123296
[TBL] [Abstract][Full Text] [Related]
5. Emodin Inhibits EBV Reactivation and Represses NPC Tumorigenesis.
Wu CC; Chen MS; Cheng YJ; Ko YC; Lin SF; Chiu IM; Chen JY
Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31731581
[TBL] [Abstract][Full Text] [Related]
6. EBV reactivation as a target of luteolin to repress NPC tumorigenesis.
Wu CC; Fang CY; Hsu HY; Chuang HY; Cheng YJ; Chen YJ; Chou SP; Huang SY; Lin SF; Chang Y; Tsai CH; Chen JY
Oncotarget; 2016 Apr; 7(14):18999-9017. PubMed ID: 26967558
[TBL] [Abstract][Full Text] [Related]
7. An analysis of brachytherapy with computed tomography-guided permanent implantation of Iodine-125 seeds for recurrent nonkeratin nasopharyngeal carcinoma.
Shen X; Li Y; Zhang Y; Kong J; Li Y
Onco Targets Ther; 2015; 8():991-7. PubMed ID: 25999732
[TBL] [Abstract][Full Text] [Related]
8. Molecular markers to assess short-term disease local recurrence in nasopharyngeal carcinoma.
Xu T; Su B; Wang C; Wang S; Huang H; Pan Y; Wang D; Wei W; Claret FX; Yang H
Oncol Rep; 2015 Mar; 33(3):1418-26. PubMed ID: 25607111
[TBL] [Abstract][Full Text] [Related]
9. The role of microRNAs in nasopharyngeal carcinoma.
Tan G; Tang X; Tang F
Tumour Biol; 2015 Jan; 36(1):69-79. PubMed ID: 25427638
[TBL] [Abstract][Full Text] [Related]
10. Temporal lobe injury after re-irradiation of locally recurrent nasopharyngeal carcinoma using intensity modulated radiotherapy: clinical characteristics and prognostic factors.
Liu S; Lu T; Zhao C; Shen J; Tian Y; Guan Y; Zeng L; Xiao W; Huang S; Han F
J Neurooncol; 2014 Sep; 119(2):421-8. PubMed ID: 24986091
[TBL] [Abstract][Full Text] [Related]
11. Prognostic model for survival of local recurrent nasopharyngeal carcinoma with intensity-modulated radiotherapy.
Tian YM; Tian YH; Zeng L; Liu S; Guan Y; Lu TX; Han F
Br J Cancer; 2014 Jan; 110(2):297-303. PubMed ID: 24335924
[TBL] [Abstract][Full Text] [Related]
12. Intensity-modulated radiation therapy for T4 nasopharyngeal carcinoma. Treatment results and locoregional recurrence.
Chen JL; Huang YS; Kuo SH; Chen YF; Hong RL; Ko JY; Lou PJ; Tsai CL; Chen WY; Wang CW
Strahlenther Onkol; 2013 Dec; 189(12):1001-8. PubMed ID: 24158634
[TBL] [Abstract][Full Text] [Related]
13. Recurrent nasopharyngeal carcinoma: a clinical dilemma and challenge.
Xu T; Tang J; Gu M; Liu L; Wei W; Yang H
Curr Oncol; 2013 Oct; 20(5):e406-19. PubMed ID: 24155638
[TBL] [Abstract][Full Text] [Related]
14. Re-irradiation combined with capecitabine in locally recurrent squamous cell carcinoma of the head and neck. A prospective phase II trial.
Vormittag L; Lemaire C; Radonjic D; Kornek G; Selzer E
Strahlenther Onkol; 2012 Mar; 188(3):235-42. PubMed ID: 22318328
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy in the therapy for recurrent/persistent nasopharyngeal cancer.
Wildeman MA; Nyst HJ; Karakullukcu B; Tan BI
Head Neck Oncol; 2009 Dec; 1():40. PubMed ID: 20017928
[TBL] [Abstract][Full Text] [Related]
16. Total biological effect on late reactive tissues following reirradiation for recurrent nasopharyngeal carcinoma.
Lee AW; Foo W; Law SC; Peters LJ; Poon YF; Chappell R; Sze WM; Tung SY; Lau WH; Ho JH
Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):865-72. PubMed ID: 10705007
[TBL] [Abstract][Full Text] [Related]
17. Reirradiation for recurrent nasopharyngeal carcinoma: factors affecting the therapeutic ratio and ways for improvement.
Lee AW; Foo W; Law SC; Poon YF; Sze WM; O SK; Tung SY; Lau WH
Int J Radiat Oncol Biol Phys; 1997 Apr; 38(1):43-52. PubMed ID: 9212003
[TBL] [Abstract][Full Text] [Related]
18. Salvage radiation therapy for locally recurrent nasopharyngeal carcinoma.
Leung TW; Tung SY; Sze WK; Sze WM; Wong VY; Wong CS; O SK
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1331-8. PubMed ID: 11121630
[TBL] [Abstract][Full Text] [Related]
19. Effect of time, dose, and fractionation on temporal lobe necrosis following radiotherapy for nasopharyngeal carcinoma.
Lee AW; Foo W; Chappell R; Fowler JF; Sze WM; Poon YF; Law SC; Ng SH; O SK; Tung SY; Lau WH; Ho JH
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):35-42. PubMed ID: 9422555
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
